ABH Healthcare IPO: ₹35 Cr Public Offering on NSE Emerge

Punjab-based healthcare provider, ABH Healthcare Limited, is preparing to launch its initial public offering (IPO) on the NSE Emerge SME platform. The company aims to raise ₹35 crore through this offering, signaling a significant step in its growth trajectory. Incorporated in 2021 and operating out of Firozpur, ABH Healthcare manages the Anil Baghi Hospital, a facility offering a broad spectrum of medical services across 25 distinct specialties. This includes advanced care in cardiac sciences, neurology, and sophisticated minimally invasive surgical procedures, catering to a growing demand for specialized medical treatments in the region.

The upcoming IPO is structured with a substantial portion, ₹33 crore, designated for fresh issuance, indicating the company's intent to reinvest capital into its operations and expansion. The remaining amount will be derived from a secondary offering. The price band for the shares has been set between ₹96 and ₹102 per share. For investors looking to participate, the minimum lot size is fixed at 1,200 shares, with retail investors needing to commit to at least two lots, translating to an investment of approximately ₹2,44,800 at the upper price limit. This pricing strategy aims to attract a diverse investor base while ensuring sufficient capital infusion for the company's strategic objectives.

The subscription window for the IPO is scheduled to open on August 24, 2026, and will conclude on August 27, 2026. Following the subscription period, the share allotment is expected on August 28, with refunds processed by August 31. The tentative listing date on the NSE Emerge platform is set for September 1, 2026. This timeline positions ABH Healthcare to capitalize on current market sentiment for healthcare sector investments, which has seen increased investor interest driven by demographic shifts and a heightened focus on health and wellness.

As of June 2026, Anil Baghi Hospital boasts a capacity of 150 beds and is supported by a dedicated medical team comprising 37 doctors and 101 nurses. The hospital's operational strength is further bolstered by its empanelment with 30 insurance providers, a crucial factor that enhances patient accessibility and financial flexibility. This extensive network of partnerships is vital in a market where insurance coverage significantly influences healthcare utilization patterns, allowing ABH Healthcare to serve a wider demographic.

Early indications suggest a positive market reception for the IPO. The grey market premium (GMP) is reportedly hovering between ₹5 and ₹25 per share, hinting at potential listing gains for early investors. This early enthusiasm is a positive signal for the company as it navigates the public markets. Fedex Securities is acting as the book running lead manager, guiding the offering, while Bigshare Services will serve as the IPO registrar, managing the administrative aspects of the share issuance. The allocation strategy prioritizes institutional investors, with qualified institutional bidders set to receive 6.12% of the stake, while non-institutional and retail investors will each be allocated 46.94% of the shares, reflecting a balanced approach to investor participation.

The Indian healthcare sector continues to be a compelling investment destination, driven by factors such as a large and growing population, increasing disposable incomes, and a rising prevalence of lifestyle-related diseases. The government's focus on improving healthcare infrastructure and accessibility further supports sector growth. Companies like ABH Healthcare, with their established operational footprint and clear expansion plans, are well-positioned to benefit from these macro trends. The successful execution of this IPO will provide ABH Healthcare with the necessary capital to enhance its service offerings, potentially expand its geographical reach, and solidify its position within the competitive healthcare provider market.